These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 33273060)

  • 1. COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Wendler D; Ochoa J; Millum J; Grady C; Taylor HA
    Science; 2020 Dec; 370(6522):1277-1279. PubMed ID: 33273060
    [No Abstract]   [Full Text] [Related]  

  • 2. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.
    Rennie S; Stürmer T
    Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200
    [No Abstract]   [Full Text] [Related]  

  • 3. The rationale for placebo-controlled trials: methodology and policy considerations.
    Miller FG
    Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193
    [No Abstract]   [Full Text] [Related]  

  • 4. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
    Dal-Ré R; Orenstein W; Caplan AL
    Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
    [No Abstract]   [Full Text] [Related]  

  • 5. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA authorizes Johnson & Johnson COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.
    Lythgoe MP; Middleton P
    JAMA Netw Open; 2021 Jun; 4(6):e2114531. PubMed ID: 34170306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
    Tcheng JE; Madan M; O'Shea JC; Cohen EA; Buller CE; Lincoff AM; Popma JJ; Teirstein PS; Kitt MM; Lorenz TJ; Greenberg S; Fost N; Califf RM
    J Interv Cardiol; 2003 Apr; 16(2):97-105. PubMed ID: 12768912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    Krause PR; Gruber MF
    N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383
    [No Abstract]   [Full Text] [Related]  

  • 10. Talk to Patients About: Vaccine Testing.
    Price S
    Tex Med; 2020 Nov; 116(11):23. PubMed ID: 33641134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo Controls: Now???
    Caplan AI
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):9. PubMed ID: 33782781
    [No Abstract]   [Full Text] [Related]  

  • 13. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Dal-Ré R
    Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
    [No Abstract]   [Full Text] [Related]  

  • 14. Audio Interview: Covid-19 Vaccine Fundamentals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Dec; 383(25):e146. PubMed ID: 33326722
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):16. PubMed ID: 35134045
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 interventions in children: a balancing act.
    Emonts M
    Arch Dis Child; 2022 Mar; 107(3):e12. PubMed ID: 34674993
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
    Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
    Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1653-1656. PubMed ID: 33382675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo control group in COVID-19 vaccine trials: context and timing matters.
    Dal-Ré R
    Eur J Clin Pharmacol; 2022 Mar; 78(3):523-526. PubMed ID: 34837495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.